A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/17 (2006.01)
Patent
CA 2603970
The present invention provides use of soluble CTLA4 mutant molecules which bind with greater avidity to the CD80 and/or CD86 antigen than wild type CTLA4 or non-mutated CTLA4Ig in the treatment of immune disorders associated with graft transplantation.
L'invention porte sur des molécules solubles de CTLA4 mutant qui se fixent avec une plus grande affinité aux antigènes CD80 et/ou CD86 que les CTLA4 de type sauvage ou que les CTLA4Ig mon mutants, pour le traitement de troubles immunologiques associés à des transplantations de greffes.
Hagerty David
Rusnak James
Bristol-Myers Squibb Company
Gowling Lafleur Henderson Llp
LandOfFree
Methods for treating immune disorders associated with graft... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for treating immune disorders associated with graft..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treating immune disorders associated with graft... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1367348